WALTHAM, Mass., April 25 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming Morgan Stanley Global Healthcare Unplugged Conference being held April 30 - May 2, 2008, at the Ritz-Carlton Key Biscayne in Florida. Ron Zwanziger, Chief Executive Officer, will attend. His presentation is scheduled for Wednesday, April 30th at 2:20 p.m. (https://events.jpmorgan.com/) During his presentation, Mr. Zwanziger may discuss and answer questions concerning business and financial developments and trends. His response to questions, as well as other matters discussed, may contain or constitute information that has not been disclosed previously.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. DATASOURCE: Inverness Medical Innovations, Inc.
CONTACT: Doug Guarino, Director of Corporate Relations, Inverness Medical Innovations, Inc., +1-781-647-3900 Web site: http://www.invernessmedical.com/
|